Dexamethasone Acetate | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Dexamethasone Acetate
HEALTH CANADA PATENTS

PharmaCompass Sponsored Ads

Contact Supplier

Symbiotec Dexamethasone

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Dexamethasone Acetate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

73 API Suppliers, 26 USDMF, 9 CEP/COS, 6 JDMF, 2 EU WC, 7 KDMF, 26 NDC API, 2 VMF, 50 Listed Suppliers, $ API Reference Price

73 API Suppliers
26 USDMF
9 CEP/COS
6 JDMF
2 EU WC
7 KDMF
26 NDC API
2 VMF
50 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

218 Drugs in Development

218 Drugs in Development

INTERMEDIATES

2 Intermediates Suppliers

2 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

361 FDF Dossiers, 130 FDA Orange Book, 113 Europe, 27 Canada, 10 Australia, 17 South Africa, 64 Listed Dossiers

361 FDF Dossiers
130 FDA Orange Book
113 Europe
27 Canada
10 Australia
17 South Africa
64 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION/DROPS;OPHTHALMIC - 0.1%, SUSPENSION/DROPS;OTIC - 0.3%;0.1%, OINTMENT;OPHTHALMIC - 0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM, SUSPENSION/DROPS;OPHTHALMIC - 0.1%;0.3%, OINTMENT;OPHTHALMIC - 0.1%;0.3%, SUSPENSION/DROPS;OPHTHALMIC - 0.05%;0.3%, TABLET;ORAL - 1.5MG, TABLET;ORAL - 0.5MG, TABLET;ORAL - 4MG, TABLET;ORAL - 0.75MG, TABLET;ORAL - 2MG, SOLUTION;ORAL - 0.5MG/5ML, ELIXIR;ORAL - 0.5MG/5ML, TABLET;ORAL - 1MG, TABLET;ORAL - 6MG

SUSPENSION/DROPS;OPHTHALMIC - 0.1%
SUSPENSION/DROPS;OTIC - 0.3%;0.1%
OINTMENT;OPHTHALMIC - 0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM
SUSPENSION/DROPS;OPHTHALMIC - 0.1%;0.3%
OINTMENT;OPHTHALMIC - 0.1%;0.3%
SUSPENSION/DROPS;OPHTHALMIC - 0.05%;0.3%
TABLET;ORAL - 1.5MG
TABLET;ORAL - 0.5MG
TABLET;ORAL - 4MG
TABLET;ORAL - 0.75MG
TABLET;ORAL - 2MG
SOLUTION;ORAL - 0.5MG/5ML
ELIXIR;ORAL - 0.5MG/5ML
TABLET;ORAL - 1MG
TABLET;ORAL - 6MG

RELATED EXCIPIENT COMPANIES

4 Rochem International Inc, 7 SPI Pharma, 8 DKSH, 2 Jai Radhe Sales, 1 Pharm-RX Chemical, 13 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 15 Actylis, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 BASF, 10 Corel Pharma Chem, 1 Curia, 6 DFE Pharma, 3 Finar, 8 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 36 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 1 Nanjing Bold Chemical, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 30 Roquette, 15 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

70 Fillers, Diluents & Binders, 45 Coating Systems & Additives, 31 Direct Compression, 28 Thickeners and Stabilizers, 25 Solubilizers, 22 Controlled & Modified Release, 20 Parenteral, 20 Topical, 19 Film Formers & Plasticizers, 19 Disintegrants & Superdisintegrants, 17 Co-Processed Excipients, 17 Taste Masking, 16 Granulation, 13 Lubricants & Glidants, 9 Chewable & Orodispersible Aids, 9 Rheology Modifiers, 7 Emulsifying Agents, 5 Empty Capsules, 5 API Stability Enhancers, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 2 Coloring Agents, 1 Soft Gelatin

70 Fillers, Diluents & Binders
45 Coating Systems & Additives
31 Direct Compression
28 Thickeners and Stabilizers
25 Solubilizers
22 Controlled & Modified Release
20 Parenteral
20 Topical
19 Film Formers & Plasticizers
19 Disintegrants & Superdisintegrants
17 Co-Processed Excipients
17 Taste Masking
16 Granulation
13 Lubricants & Glidants
9 Chewable & Orodispersible Aids
9 Rheology Modifiers
7 Emulsifying Agents
5 Empty Capsules
5 API Stability Enhancers
4 Vegetarian Capsules
4 Surfactant & Foaming Agents
2 Coloring Agents
1 Soft Gelatin

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 264 NEWS #PharmaBuzz

3 DATA COMPILATION #PharmaFlow
264 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

7 US Medicaid Prescriptions, 110 Finished Drug Prices, 6 Annual Reports

7 US Medicaid Prescriptions
110 Finished Drug Prices
6 Annual Reports

MARKET PLACE

61 APIs, 59 FDF Dossiers

61 APIs
59 FDF Dossiers

PATENTS & EXCLUSIVITIES

16 US Patents, 3 US Exclusivities, 3 Health Canada Patents

16 US Patents
3 US Exclusivities
3 Health Canada Patents

REF. STANDARDS & IMPURITIES

8 EDQM, 2 USP, 2 JP, 8 Others

8 EDQM
2 USP
2 JP
8 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 698 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

3 All

01 2AbbVie Corporation

02 1Gowling WLG (Canada) LLP

filter Patent Reset all filters

3 All

01 12414680

02 12429998

03 12512315

filter Product Reset all filters

3 All

01 3Dexamethasone

filter Dosage Reset all filters

3 All

01 3Intravitreal injection

filter Exp Date Reset all filters

3 All

01 12021-07-03

02 12021-11-28

03 12024-01-07

EUROAPI Dexamethasone

Product Main Page

01

AbbVie Corporation

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-11-28

Date Granted : 2012-01-17

Dexamethasone

Brand Name : OZURDEX

Patent Number : 2429998

Filing Date : 2001-11-28

Strength per Unit : 0.7 mg

Dosage Form : Intravitreal injection

Human Or VET : Human

Route of Administration : Intravenous Injection

Patent Expiration Date : 2021-11-28

Date Granted : 2012-01-17

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gowling WLG (Canada) LLP

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-07-03

Date Granted : 2007-09-18

Dexamethasone

Brand Name : OZURDEX

Patent Number : 2414680

Filing Date : 2001-07-03

Strength per Unit : 0.7 mg

Dosage Form : Intravitreal injection

Human Or VET : Human

Route of Administration : Intravenous Injection

Patent Expiration Date : 2021-07-03

Date Granted : 2007-09-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

AbbVie Corporation

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-01-07

Date Granted : 2008-12-30

Dexamethasone

Brand Name : OZURDEX

Patent Number : 2512315

Filing Date : 2004-01-07

Strength per Unit : 0.7 mg

Dosage Form : Intravitreal injection

Human Or VET : Human

Route of Administration : Intravenous Injection

Patent Expiration Date : 2024-01-07

Date Granted : 2008-12-30

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?